Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Veltri

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
BJU International|December 18, 2015
Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancerRobert W Veltri
Urologic Oncology|December 2, 2006
Nucleic acid-based marker approaches to urologic cancersRobert W Veltri, Danil V Makarov
Advances in Experimental Medicine and Biology|February 25, 2014
Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancerRobert W Veltri, Christhunesa S Christudass
Asian Journal of Andrology|April 17, 2012
Nuclear morphometry, nucleomics and prostate cancer progressionRobert W Veltri, Christhunesa S Christudass, Sumit Isharwal
Journal of Cellular Biochemistry|June 21, 2018
Advances in the computational and molecular understanding of the prostate cancer cell nucleusNeil M Carleton, George Lee, Anant Madabhushi, et al.
Journal of Cellular Biochemistry|February 3, 2015
The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate CancerZhi Liu, Guangjing Zhu, Robert H Getzenberg, et al.
The Prostate|October 21, 2014
Epithelial-mesenchymal transition in prostate cancer is associated with quantifiable changes in nuclear structureJames E Verdone, Princy Parsana, Robert W Veltri, et al.
Urology|October 18, 2002
Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancerRobert W Veltri, M Craig Miller, Gerard J O'dowd, et al.
Plos One|April 9, 2015
Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancerJi Li, Robert W Veltri, Zhen Yuan, et al.
Reviews in Urology|September 21, 2006
Modern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI)Matthew B Gretzer, Alan W Partin, Daniel W Chan, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
BJU International|December 18, 2015
Serum marker %[-2]proPSA and the Prostate Health Index improve diagnostic accuracy for clinically relevant prostate cancerRobert W Veltri
Urologic Oncology|December 2, 2006
Nucleic acid-based marker approaches to urologic cancersRobert W Veltri, Danil V Makarov
Advances in Experimental Medicine and Biology|February 25, 2014
Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancerRobert W Veltri, Christhunesa S Christudass
Asian Journal of Andrology|April 17, 2012
Nuclear morphometry, nucleomics and prostate cancer progressionRobert W Veltri, Christhunesa S Christudass, Sumit Isharwal
Journal of Cellular Biochemistry|June 21, 2018
Advances in the computational and molecular understanding of the prostate cancer cell nucleusNeil M Carleton, George Lee, Anant Madabhushi, et al.
Journal of Cellular Biochemistry|February 3, 2015
The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate CancerZhi Liu, Guangjing Zhu, Robert H Getzenberg, et al.
The Prostate|October 21, 2014
Epithelial-mesenchymal transition in prostate cancer is associated with quantifiable changes in nuclear structureJames E Verdone, Princy Parsana, Robert W Veltri, et al.
Urology|October 18, 2002
Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancerRobert W Veltri, M Craig Miller, Gerard J O'dowd, et al.
Plos One|April 9, 2015
Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancerJi Li, Robert W Veltri, Zhen Yuan, et al.
Reviews in Urology|September 21, 2006
Modern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI)Matthew B Gretzer, Alan W Partin, Daniel W Chan, et al.
Pageof 7